An increase in ACE2 expression was also recently reported in the kidney of patients with diabetic kidney disease (92) and in the liver of patients with diabetes and also subjects with non-alcoholic fatty liver, which is prevalent in subjects with prediabetes (93). Here, ACE2 is linked to diabetes mellitus.